Outcomes Study: Health-System Specialty Pharmacy Support for Weight Loss Medication Management in Patients Without Type 2 Diabetes - Outcomes from a Single Health System

Members of our team had the opportunity to present a new poster abstract at AMCP 2026, which was held from April 13-16, 2026. 

Authors

Andrew Wash, PharmD PhD; Chris Tomaino, PharmD; Erin Waters, PharmD; Jenna Daley, CPhT; Ana Lopez medina, PharmD, PhD; Casey Fitzpatrick, PharmD; Alesia Sypniewski, PharmD; Nicolina Castilla, PharmD

Background

• Nearly three-quarters of U.S. adults are overweight or obese, creating a critical need for effective weight management strategies.¹

• Pharmacologic therapies, including GLP-1 and GIP/GLP-1 receptor agonists, are valuable tools, though access challenges such as medication shortages, limited insurance coverage, and high out-of-pocket costs persist.^2,3

• Health-system specialty pharmacy (HSSP) teams are well positioned to support patients through medication management and clinical monitoring.

Objectives

To evaluate medication access and clinical outcomes among patients enrolled in an HSSP-led chronic disease management (CDM) program for weight loss.